[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100360815":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":38,"centralContacts":49,"locations":58,"responsibleParty":95,"collaborators":97,"id":100,"slug":101,"hasResults":102,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":106,"eligibilityCriteria":107,"healthyVolunteers":102,"sex":108,"minAge":10,"maxAge":10,"enrollmentInfo":109,"targetDuration":112,"studyType":113,"phases":10,"briefSummary":114,"conditions":115,"keywords":117,"overallStatus":61,"whyStopped":10,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":131},{"fullName":5,"class":6},"Institut Bergonié","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with sarcoma",null,"Patients with a sarcoma diagnosed in a French Comprehensive cancer Center",[13,14,15,16,17],"Drug: Chemotherapy","Drug: Immunotherapeutic Agent","Drug: target treatment","Procedure: Surgery","Radiation: Radiotherapy",[19,24,27,30,34],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DRUG","Chemotherapy","treatment as per standard of care",[9],{"type":20,"name":25,"description":22,"armGroupLabels":26,"otherNames":10},"Immunotherapeutic Agent",[9],{"type":20,"name":28,"description":22,"armGroupLabels":29,"otherNames":10},"target treatment",[9],{"type":31,"name":32,"description":22,"armGroupLabels":33,"otherNames":10},"PROCEDURE","Surgery",[9],{"type":35,"name":36,"description":22,"armGroupLabels":37,"otherNames":10},"RADIATION","Radiotherapy",[9],[39,43,46],{"name":40,"affiliation":41,"role":42},"Maud Toulmonde, MD","Institut Bergonié, Bordeaux, France","STUDY_CHAIR",{"name":44,"affiliation":45,"role":42},"Axel Le Cesne, MD\u002FPhD","Institut Gustave Roussy, Villejuif, France",{"name":47,"affiliation":48,"role":42},"Jean-Yves Blay, MD\u002FPhD","Centre Léon Bérard, Lyon, France",[50,54],{"name":40,"role":51,"phone":52,"phoneExt":10,"email":53},"CONTACT","0556333333","m.toulmonde@bordeaux.unicancer.fr",{"name":55,"role":51,"phone":56,"phoneExt":10,"email":57},"Simone Mathoulin-Pélissier, MD\u002FPhD","05563333","s.mathoulin@bordeaux.unicancer.fr",[59,75,85],{"facility":60,"status":61,"city":62,"state":10,"zip":10,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Institut Bergonié, Comprehensive Cancer Center","RECRUITING","Bordeaux","France","FR",{"type":66,"coordinates":67},"Point",[68,69],-0.58046,44.84124,{"lat":69,"lon":68},[72,73],{"name":40,"role":51,"phone":10,"phoneExt":10,"email":10},{"name":74,"role":51,"phone":10,"phoneExt":10,"email":10},"Antoine Italiano, MD\u002FPhD",{"facility":76,"status":61,"city":77,"state":10,"zip":10,"country":63,"countryCode":64,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Centre Léon Bérard","Lyon",{"type":66,"coordinates":79},[80,81],4.84789,45.74906,{"lat":81,"lon":80},[84],{"name":47,"role":51,"phone":10,"phoneExt":10,"email":10},{"facility":86,"status":61,"city":87,"state":10,"zip":10,"country":63,"countryCode":64,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Institut Gustave Roussy, Comprehensive Cancer Center","Villejuif",{"type":66,"coordinates":89},[90,91],2.35992,48.7939,{"lat":91,"lon":90},[94],{"name":44,"role":51,"phone":10,"phoneExt":10,"email":10},{"type":96,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[98],{"name":99,"class":6},"French Sarcoma Group","100360815","national-clinical-and-biological-sarcoma-database--an-initiative-of-the-french-sarcoma-group-100360815",false,"NCT03978039","National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group","The \"BCB-sarcomes\" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas","BCB-Sarcomes","Inclusion criteria :\n\n* Diagnosis of sarcoma\n* Diagnosis in a French Comprehensive Cancer Center\n* Any age","ALL",{"count":110,"type":111},150000,"ESTIMATED","10 Years","OBSERVATIONAL","The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \\[RESOS\\] \u002F French expert network dedicated to the pathology of sarcomas \\[RREPS\\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS \u002F French expert clinical network for sarcomas \\[NETSARC\\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE \u002F BONE \u002F GIST) is dedicated to collecting patients longitudinal\u002Ffollow up data, with a focus on treatments of every events, and a catalogue of associated samples.\n\nPrimary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.\n\nWith the financial support of the French National Cancer Institute \\[Institut National du cancer \\[INCa\\]).",[116],"Sarcoma",[118,119,120,121],"patterns of care","access to care","survival","experts' network","2025-08-28",{"date":124,"type":125},"2025-09-04","ACTUAL",{"date":127,"type":125},"2010-01-01",{"date":129,"type":111},"2035-12-31",{"name":5,"class":6},3]